Latest Cost Reduction News

Page 6 of 81
SkyCity has reiterated its FY27 earnings outlook after first-quarter trading remained in line with expectations, despite subdued consumer conditions in New Zealand and Australia. Cost savings are running ahead of schedule, but one-off charges, online casino investment and the absence of formal guidance leave the recovery heavily execution-dependent.
Victor Sage
Victor Sage
21 Oct 2026
Ovanti sharply reduced its quarterly operating cash outflow to A$491,096, helped by higher customer receipts and cost reductions. But with only A$227,000 in cash, the ASX-listed fintech remains dependent on further funding, operating receipts and uncertain legal recoveries.
Victor Sage
Victor Sage
20 Oct 2026
Freelancer returned to operating profit in 3Q26 after cutting operating expenses 11%, but its core marketplace remained under pressure. Record activity at Loadshift and stronger Escrow.com GMV provided the brighter spots while management works to restore demand at Freelancer.
Sophie Babbage
Sophie Babbage
20 Oct 2026
Bellevue Gold has kept FY27 production and cost guidance intact despite a slower-than-expected mining contractor ramp-up that reduced September-quarter output to 35,585 ounces. The company also cut forward sales commitments to 57.5koz, increasing its future exposure to spot gold prices while capital spending weighed on free cash flow.
Maxwell Dee
Maxwell Dee
20 Oct 2026
K&S Corporation’s FY2026 annual report confirms a sharp earnings decline, a lower dividend and rising debt as weak demand, margin pressure and the loss of most InfraBuild work weigh on the logistics group. Management expects FY2027 to remain difficult, with no formal earnings guidance provided.
Victor Sage
Victor Sage
19 Oct 2026
Advanced Braking Technology increased Q1 FY27 product sales by 8.3% and ended September with $7.3 million in bank cash. The mining safety company also moved BRAKEiQ closer to CAS Level 9 certification, although the quarter produced a small loss before tax.
Victor Sage
Victor Sage
19 Oct 2026
Coventry Group’s Q1 FY27 EBITDA nearly doubled to A$5.4 million as cost reductions and margin gains began to outweigh modest sales growth. Leverage has also halved from its March peak, although the strategic review has yet to produce a transaction.
Victor Sage
Victor Sage
16 Oct 2026
Titomic will restructure its Australian and US operations and reduce consultant spending, targeting A$3.0 million in annualised operating cost savings. The company expects to complete the changes by October’s end while repositioning Australia as its global research and development centre.
Victor Sage
Victor Sage
15 Oct 2026
Treasury Wine Estates has reiterated its FY27 earnings guidance after a bruising year marked by a $1.1 billion statutory loss, a suspended dividend and a major US reset. Early trading indicators are improving, but the recovery now depends on execution across costs, inventory, supply and the Americas review.
Victor Sage
Victor Sage
15 Oct 2026
FOS Capital has started FY27 ahead of its own expectations, reporting a 64% rise in quarterly sales and a stronger-than-forecast EBITDA result. The order book has expanded to $10.5 million, while major lighting wins and a $130 million quote pipeline support management’s expectation of similarly strong sales in 2Q27.
Victor Sage
Victor Sage
14 Oct 2026
Genetic Signatures reduced its quarterly operating cash outflow to A$1.0 million after restructuring, while commercial testing began under its Danish hospital contract. The company is also advancing an all-scrip Microba merger, but faces a contested shareholder meeting later this month.
Ada Torres
Ada Torres
8 Oct 2026
Trajan Scientific and Medical (ASX:TRJ) says FY27 has begun with improving revenue, quarterly nEBITDA of about A$3.5 million and a A$1.6 million reduction in net debt. The company expects mid-single-digit organic revenue growth and double-digit nEBITDA growth for the year, although its latest quarterly figures remain unaudited.
Victor Sage
Victor Sage
8 Oct 2026

Browse the archive

Full archive